Reported 24 days ago
Pfizer's CEO, Albert Bourla, outlined three main strategies for enhancing the company's productivity and cost reduction during a recent earnings call. He emphasized the importance of focus, technological advancements, and restructuring to eliminate waste. Despite facing challenges from potential tariff threats and price reduction pressures, Pfizer managed to achieve a 10% revenue growth in the second quarter, with new products contributing significantly to the earnings. Bourla also highlighted an ongoing dialogue with the Trump administration to address industry-related concerns.
Source: YAHOO